Trial 0C-15-4


A Phase 1a/1b Study of Cabiralizumab in Combination with Nivolumab in Patients with Selected Advanced Cancers

Type: Treatment
Phase: Phase I
Status: Not Open (Closed)
Treatments: Immunotherapy
Randomized: No
USC Satellite Location: None
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Anthony El-Khoueiry, M.D.
Other Trial Staff:  Alicia Bogardus, Coordinator, Cristina De Leon, Coordinator, Deborah Fridman, Coordinator, Anayansi Miloud, D.M., Xiomara Menendez, R.N., Noureddine Miloud, D.M., Jessica Levano, Coordinator, Jubilee Acap, R.N., Khatchik Karakozian, D.M., Molly Oswald, R.N., Sherine Elsayegh, Coordinator, Jennifer Cano, D.M., Hany Ghattas, Coordinator, Karen Koeller, Coordinator, Atessa Kiani, Coordinator, Atessa Kiani, Coordinator

Staff may log in to see study documents.

Click here to see trial eligibility criteria and further details at ClinicalTrials.gov





For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3300.